Prof Jeff Carroll has been our longstanding Scientific Advisor since CureDRPLA was founded and after seven years in the role he has resigned to pursue new opportunities. While we will miss Jeff on our team, we are grateful for the time he spent with us and for the scientific expertise he brought to the role.
Jeff was instrumental in setting the direction of CureDRPLA and shaped our strategy for which therapeutic modalities to prioritize. A key milestone driven by Jeff was the development of mouse models of DRPLA to test possible treatments.
We thank Jeff for his many contributions and wish him every success in his next chapter. He leaves big shoes to fill; however, we are exploring our options and hope to appoint a replacement soon.